Therapy for SIAD: what does the future hold?

Ther Adv Endocrinol Metab

Division of Medicine, Department of Metabolism & Experimental Therapeutics, University College London Medical School, Gower Street, London WC1E6BT, UK.

Published: April 2023

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10123912PMC
http://dx.doi.org/10.1177/20420188231166493DOI Listing

Publication Analysis

Top Keywords

therapy siad
4
siad future
4
future hold?
4
therapy
1
future
1
hold?
1

Similar Publications

Background: Older age and associated comorbid conditions increase the risk of severe form of COVID-19 and death. The SARS-CoV-2 vaccination campaign began in France in December 2020 targeting institutionalized older population before having been evaluated in this population. The objective of our study was to assess the tolerability of vaccination 21 days (D21) and 90 days after the first vaccination (D90) in institutionalized old people.

View Article and Find Full Text PDF

Syndrome of inappropriate antidiuresis (SIAD)-the most frequent cause of hypotonic hyponatremia-is mediated by nonosmotic release of arginine vasopressin, which promotes water retention by activating renal vasopressin type 2 (V2) receptors. There are numerous causes of SIAD, including malignancy, pulmonary and central nervous system diseases, and medications. Rare activating mutations of the V2 receptor can also cause SIAD.

View Article and Find Full Text PDF

Empagliflozin: a wonder drug for the treatment of SIAD?

Front Endocrinol (Lausanne)

October 2024

Department of Metabolism & Experimental Therapeutics, Division of Medicine, University College London, London, United Kingdom.

View Article and Find Full Text PDF

How we approach steroid-induced affective disorder in pediatric oncology.

Pediatr Blood Cancer

December 2024

Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.

High-dose corticosteroids are an essential component of treatment for pediatric cancers. Yet, these agents often cause psychiatric disturbances including sleep disruption, steroid-induced psychosis, and steroid-induced affective disorder (SIAD). SIAD, identified as a specific form of substance/medication-induced mental disorder, can present with various psychiatric symptoms, including mania, depression, irritability, and inconsolability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!